Spyre Therapeutics (SYRE) Common Equity (2015 - 2026)
Spyre Therapeutics' Common Equity was $1.05 billion in Q3 2026, up 131.1% from $455.1 million a year earlier but down 4.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Spyre Therapeutics came in at $715.24 million, up 38.1% from FY2024.
- Common Equity has now increased for three consecutive years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $517.8 million in FY2024 (+181.4%), $184.02 million in FY2023 (+265.8%), $50.31 million in FY2022 (-40.1%) and $83.94 million in FY2021 (-40.0%).
- Quarterly Common Equity has moved between -$245.4 million (Q3 2023) and $1.1 billion (Q2 2026) over five years.
- Compared with a year earlier, Common Equity has increased for eight straight quarters, with growth averaging 101.1% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 352.5%); the worst was Q1 2022 (a decline of 50.2%).
- Per Business Quant data, SYRE's Common Equity in the three quarters before Q3 2026 was $1.1 billion (Q2 2026), $670.81 million (Q1 2026) and $715.24 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Spyre Therapeutics | 9.45 Bn | 5.73 Bn | - | 1.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.05 Bn |
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 670.81 Mn |
| Dec 31, 2025 | 715.24 Mn |
| Sep 30, 2025 | 455.10 Mn |
| Jun 30, 2025 | 455.77 Mn |
| Mar 31, 2025 | 482.61 Mn |
| Dec 31, 2024 | 517.80 Mn |
| Sep 30, 2024 | 327.39 Mn |
| Jun 30, 2024 | 374.39 Mn |
| Mar 31, 2024 | 152.27 Mn |
| Dec 31, 2023 | 184.02 Mn |
| Sep 30, 2023 | -245.40 Mn |
| Jun 30, 2023 | -207.37 Mn |
| Mar 31, 2023 | 33.65 Mn |
| Dec 31, 2022 | 50.31 Mn |
| Sep 30, 2022 | 67.56 Mn |
| Jun 30, 2022 | 84.16 Mn |
| Mar 31, 2022 | 61.66 Mn |
| Dec 31, 2021 | 83.94 Mn |
API Access
Spyre Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();